2-Bromo-4,5-Dimethoxy Chalcone Inhibits Cisplatin-induced LLC-PK1 Kidney Cell Death

Authors
Lee, DahaeLee, HeesuKang, Ki SungLee, Jae Wook
Issue Date
2018-05
Publisher
대한화학회
Citation
Bulletin of the Korean Chemical Society, v.39, no.5, pp.699 - 702
Abstract
The kidney has various functions, including modulating blood pressure, balancing electrolytes, and controlling blood volume. Among these functions, extracting metabolic waste from blood plays an important role in kidney. 1,2 Additionally, kidney epithelial cells are vulnerable to the toxic effects of various chemical agents and medications. 3,4 Recently, cisplatin, an inorganic platinum-based chemotherapeutic agent, has been used to inhibit solid malignant tumors due to its high therapeutic potential. 5,6 However, continuous exposure to cisplatin can cause various significant side effects, such as bone marrow suppression, peripheral neuropathy, and nephrotoxicity. In particular, a single dose of cisplatin treatment can cause nephrotoxicity among one-third of patients.(7-9) Therefore, it has been suggested to develop medication for cisplatin-induced nephrotoxicity.
Keywords
BIOLOGICAL EVALUATION; INDUCED CYTOTOXICITY; TYROSINE KINASE; AGENTS; ANALOGS; APOPTOSIS; INJURY; ISOLIQUIRITIGENIN; PATHWAYS; DESIGN; Chalcone; Cisplatin; Kidney cells; Renoprotection; MAPK pathway
ISSN
0253-2964
URI
https://pubs.kist.re.kr/handle/201004/121428
DOI
10.1002/bkcs.11454
Appears in Collections:
KIST Article > 2018
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE